Moleculin Biotech (MBRX) Return on Assets [ROA] (2016 - 2026)
Moleculin Biotech (MBRX) recorded Return on Assets [ROA] of -123.67% in Q2 2026, down 4.24 percentage points from -119.42% a year earlier.
Powered by 
Analysis
Moleculin Biotech (MBRX) Return on Assets [ROA] (2016 - 2026) Analysis & Trends
For FY2025, Moleculin Biotech reported Return on Assets [ROA] of -128.57%, down 31.94 percentage points from FY2024.
- Annual Return on Assets [ROA] has declined for four straight years, with a five-year change of -64.60 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Assets [ROA] came in at -96.63% in FY2024 (-34.66 pp), -61.96% in FY2023 (-18.66 pp), -43.30% in FY2022 (-2.70 pp) and -40.61% in FY2021 (+23.35 pp).
- The Q2 2026 figure is the lowest quarterly Return on Assets [ROA] since Q1 2025.
- On a year-over-year basis, Return on Assets [ROA] rose in two of the last seven quarters, with an average year-over-year change of -24.90 percentage points.
- Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 36.69 percentage points in Q3 2021, against a drop of 55.92 percentage points in Q4 2024 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | Moleculin Biotech | 2.84 Mn | 2.84 Mn | - | -123.67% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -123.67% |
| Dec 31, 2025 | -118.19% |
| Sep 30, 2025 | -115.44% |
| Jun 30, 2025 | -119.42% |
| Mar 31, 2025 | -136.57% |
| Dec 31, 2024 | -132.15% |
| Sep 30, 2024 | -118.10% |
| Jun 30, 2024 | -98.29% |
| Mar 31, 2024 | -80.95% |
| Dec 31, 2023 | -76.23% |
| Sep 30, 2023 | -64.08% |
| Jun 30, 2023 | -62.94% |
| Mar 31, 2023 | -58.85% |
| Dec 31, 2022 | -49.90% |
| Sep 30, 2022 | -41.55% |
| Jun 30, 2022 | -34.03% |
| Mar 31, 2022 | -29.41% |
| Dec 31, 2021 | -26.58% |
| Sep 30, 2021 | -22.39% |
| Jun 30, 2021 | -18.25% |
API Access
Moleculin Biotech Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=MBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "MBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=MBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();